NCT05459415View on ClinicalTrials.gov

Reducing Excision Margins After Neoadjuvant Chemoimmunotherapy for HPV Negative Resectable Locally Advanced HNSCC

NAActive, not recruitingINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

June 22, 2022

Primary Completion Date

June 21, 2025

Study Completion Date

June 21, 2027

Conditions
Squamous Cell Carcinoma of Head and NeckNeoadjuvant TherapyResection Margin
Interventions
PROCEDURE

Reducing Excision Margins

Reducing Excision Margins After Neoadjuvant Chemoimmunotherapy

Trial Locations (1)

430030

Zhanjie Zhang, Wuhan

All Listed Sponsors
lead

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

OTHER